Aehr Test Systems
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -114.0% | – | – | +94.4% | -346.8% | – | – | – | – | – | – | – | |
| – | +5.1% | +155.9% | +0.3% | +52.2% | +57.8% | +1.8% | +12.2% | -9.6% | -5.5% | -1.3% | -83.0% | – | |
| – | +22.2% | -8.5% | +32.5% | +12.4% | +23.6% | +67.1% | -20.9% | +17.6% | +110.2% | -108.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -4,799.3% | – | – | – | – | – | – | – | |
| – | -45.1% | +68.6% | -82.5% | +328.3% | +62.9% | +415.9% | +70.2% | -50.6% | -66.4% | -84.2% | +81.1% | – | |
| – | -100.9% | +68.6% | -82.5% | +23,404.3% | -97.0% | +559.2% | +33.2% | -50.6% | +63.0% | -96.7% | +81.1% | – | |
| – | -55.7% | -95.5% | +480.0% | +39.7% | +11.7% | -2.2% | +49.2% | +24.2% | +49.7% | -7.5% | +140.3% | – | |
| – | – | -37.8% | +166.5% | -125.2% | – | -119.2% | – | -162.9% | – | +0.5% | +691.2% | – | |
| – | -102.1% | – | – | -817.9% | – | – | – | – | – | -26.6% | +1,207.6% | – | |
| – | -119.4% | – | – | +85.3% | -383.7% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.